Cell Metabolism, launched in January 2005, is a leading journal focusing on physiology, with an emphasis on understanding the molecular basis of how the body self-regulates in the face of change, and how disturbances in these balances can lead to disease. The journal's mission is to provide a forum for the exchange of ideas and concepts across the entire metabolic research community, cultivating new areas and fostering cross-disciplinary collaborations in basic research and clinical investigation.
As part of the journal's commitment that their Advisory Board, formerly known as the Editorial Board, should consist of voices that reflect the metabolism community that it leads, the journal invited Associate Professor Ana Domingos to join the Board.
According to Cell Metabolism's Editor-in-Chief Allyson Evans: "Importantly, the Board should be individuals whose expertise covers the breadth of the topics that the journal publishes, whose research is trusted and has shaped the field, and importantly whose service as a reviewer is fair, thoughtful and constructive to his or her colleagues.
In thinking of these criteria, we realise that Ana Domingos has played a large part in shaping Cell Metabolism into the success it is today. Not only do we and the community value the contributions that her research has made to the field, we find that her comments as a reviewer and the more informal expert advice that she has given our editors over the years has improved the research of those she has critiqued, and has made the papers we publish of higher quality."
Prof Domingos commented: "It is a true honour to accept the invitation to integrate the advisory board of Cell Metabolism, which is the top journal in obesity research. I received this invitation because, as Allyson Evans says, my research is trusted and has shaped the field, and my service as a reviewer is fair, thoughtful and constructive to my colleagues."
Recent research from Prof Domingos published in Cell Metabolism, "Brain-Sparing Sympathofacilitators Mitigate Obesity without Adverse Cardiovascular Effects", outlined the development of a new weight-loss amphetamine that could potentially avoid the harmful side effects of traditional treatments.
More information about the Cell Metabolism Advisory Board can be found on the Cell Metabolism website.